A digital twin in healthcare is a live, data-fed model of a patient, an organ or a hospital process that clinicians and operators can test decisions against before touching the real thing. This guide is for the CIO, CMIO or compliance director who has to decide whether digital twin technology in healthcare is ready for their healthcare system. It covers the applications of digital twin projects that are producing results for patient care today, the honest challenges of digital twin programs, where protected health information moves through one, and the HIPAA and HITRUST controls an auditor will expect to see. If a vendor has pitched you a digital twin for healthcare this year, read this before the second meeting.
What is a digital twin in healthcare?
A digital twin is a virtual model of a physical thing that stays connected to it. Sensor readings, lab results and operational events flow into the model, the model updates, and its outputs flow back into decisions about the physical counterpart. That two-way loop is what separates a digital twin from a one-off simulation. NIST's report on security and trust considerations for digital twin technology points out that twins inherit the usual cybersecurity problems and add some that are new to the technology, largely because of that constant connection.
In practice, a digital twin in healthcare comes in three sizes. A patient digital twin, sometimes called a digital patient, is a digital representation of one person, built from their imaging, labs, genomics and device data to personalize care. An organ twin, such as a patient-specific heart model, is a narrower model used to plan a procedure. A hospital twin is a digital model of beds, staff, operating rooms and patient flow. A human digital twin of the whole body, a complete digital replica of a human, is the version that shows up in conference keynotes, and it is still a research goal.
The promise for any use in healthcare is the same at every size: run the experiment on the model first. Digital twins provide a safe place to test. They allow healthcare providers to simulate a drug dose, a surgical approach or a staffing plan and see the likely result before committing a patient or a shift to it.
How is a medical digital twin different from a simulation or an EHR dashboard?
A twin is easy to confuse with tools hospitals already own. A simulation is a model you run once with assumptions you chose; it doesn't update itself when the patient changes. An electronic health record (EHR) dashboard shows what has already happened, pulled from health records, but it doesn't predict or test anything. A twin does both jobs: it ingests live data like a dashboard and runs forward like a simulation.
The difference matters for procurement. Plenty of products sold as twins are really dashboards with a forecasting widget, or simulations refreshed once a quarter. Ask the vendor how often the model updates, which data sources feed it, and whether its outputs change any decision automatically or only inform a clinician. If the answers are "monthly," "a spreadsheet export" and "neither," you are buying analytics, which may be fine, but it shouldn't be priced as a twin.
How big is the global digital twins in healthcare market?
As with much of digital health, market forecasts vary wildly, which tells you how early this is. MarketsandMarkets valued the sector at $1.6 billion in 2023 and projected growth to $21.1 billion by 2028, a 67% compound annual rate. Other firms publish very different numbers for the same period, because they disagree on what counts as a twin.
Treat any single forecast as a signal of vendor investment, not of clinical maturity. Digital twins in the healthcare industry attract real money: medical device makers, EHR vendors and cloud providers all have digital twin platform offerings, and that spending shapes what your health system will be pitched. The potential of digital twin technology is real, but a growing market does not mean a validated product. If you want the evidence base, start with a systematic literature review rather than vendor case studies. A 2024 scoping review in npj Digital Medicine, Digital twins for health, concluded that digital twins for health are still in their early stages, with most work in research settings.
Where healthcare digital twins deliver value today: patients, organs and hospital operations
Among healthcare applications, the most mature digital twin use cases are operational. In the command centers of large healthcare facilities, digital twins are employed to predict bed demand, discharge timing and emergency department surges, and teams try staffing changes in these digital twin enabled views before making them. These digital twins can optimize operating room schedules and transfer decisions because the data is already structured and the decisions are reversible. Operations leaders already get valuable insights for healthcare capacity planning from them, and the benefits of digital twin work are easiest to measure in this setting. If you're starting anywhere, start here.
Organ-level digital twin applications are next in maturity. Cardiology and orthopedics teams use patient-specific models built from imaging to plan device placement and rehearse complex procedures. When a digital twin model like this supports a device submission, the FDA expects evidence that it's trustworthy, and its guidance on assessing the credibility of computational modeling sets out a risk-based framework for that. Note the scope: it covers physics-based and mechanistic models, not machine-learning models.
Building digital replicas of patients for personalized treatment is the furthest out. Oncology and chronic-disease groups are pursuing it because these digital twins have the potential to personalize therapy choices by predicting how one patient will respond. Digital twins make it possible to compare treatment options for a single person rather than an average one. The research is promising, but very few digital twins in healthcare settings have been validated prospectively. Expect pilots, not standard care, through 2027.
What evidence shows digital twins can reduce clinical trial size?
The healthcare use with the strongest regulatory evidence so far is drug development. In September 2022, the European Medicines Agency's CHMP issued a qualification opinion for prognostic covariate adjustment (PROCOVA), the method behind what its developer, Unlearn, markets as digital twins of trial participants. A model trained on historical data predicts each participant's likely outcome on control, and that prediction is used as a covariate in the primary analysis.
The opinion says the method can increase statistical power or reduce the sample size needed for Phase 2 and Phase 3 trials with continuous outcomes, while warning that any sample-size gain should be estimated conservatively. That is the honest version of the claim that twins shrink trial enrollment: fewer participants for the same statistical confidence, not trials without control groups. Notably, EMA's text describes prognostic scores rather than using the phrase "digital twin" at all.
For a provider organization, the use of digital twin methods in drug trials matters in two ways. Academic medical centers running sponsored studies will see digital twins in clinical protocols. And any health system contributing data to train trial models needs a clear data-use agreement before that data leaves the building.
The data behind a healthcare digital twin: where PHI flows and where it leaks
A twin is only as good as the healthcare data feeding it, and those feeds are where the risk sits. A typical patient model pulls from different healthcare systems: the EHR, imaging archives, lab systems, remote monitoring devices and sometimes genomics. Each feed is an interface, each interface is credentials plus a data path, and most of them carry electronic protected health information. Large amounts of healthcare data now move continuously instead of in nightly batches.
The leak points associated with digital twins are predictable. Integration engines and APIs with over-scoped service accounts. Digital twin data copied into a data science environment for training, with weaker controls than production. Vendor-hosted models that store a full patient digital twin in a region or tenant you never reviewed. Wearable health data streamed over consumer networks. And outputs: a twin's predictions about a named patient are themselves PHI, and they often land in tools nobody classified.
De-identification is harder than vendors suggest. A detailed digital twin of a patient, with imaging, timelines and genomic markers, can be re-identifiable even after the 18 Safe Harbor identifiers are removed. If a vendor says the model is "anonymized," ask whether they used Expert Determination and request the report. Strong identity controls also matter here; our analysis of multi-factor authentication and healthcare data breaches shows how often stolen credentials are the first step.
HIPAA and HITRUST controls for a digital twin program
HIPAA has no provisions related to digital twins specifically, but the HIPAA Security Rule applies to every system that creates, receives, stores or transmits ePHI, which describes a twin exactly. The administrative, physical and technical safeguards apply: a risk analysis that covers each data feed, access controls by role, audit logging on model inputs and outputs, encryption in transit and at rest, and a business associate agreement with every vendor that touches the data. HHS proposed a major Security Rule update in January 2025; OCR's latest regulatory agenda now targets a final rule in July 2027, so build to the proposed requirements, such as asset inventories and network maps, rather than waiting.
HITRUST gives you a way to prove those controls to partners. HITRUST's assessment options range from the e1, with 44 foundational requirements, to the i1 with 182 requirements, both valid for one year, up to the r2, which is risk-based and valid for two years. If the twin platform is vendor-hosted, ask for the vendor's current HITRUST certification and its scope. A certification that covers the vendor's corporate IT but not the hosting environment for your model doesn't help you.
Most digital twin frameworks leave out model controls, so add them. Version every model and the data used to train it. Log which model version produced each prediction, so you can ensure that the digital record of every decision can be reconstructed. Restrict who can change model parameters, and test changes before release. These overlap heavily with AI governance, which we cover in our AI governance framework for healthcare. We'll compare HITRUST, HIPAA and SOC 2 side by side in an upcoming guide.
What are the biggest risks of digital twins in healthcare?
The security risk gets the attention, but the clinical risk is bigger. A twin that drifts out of sync with the patient, because a device stopped reporting or a lab feed failed silently, will keep producing confident predictions. Health systems that use digital twins to monitor patients need to show healthcare professionals the twin's data freshness, and any patient-facing use needs a fallback that patients and healthcare providers both understand. Digital twins can make a stale prediction look authoritative.
Bias is the second risk, and the healthcare domain makes it sharper. A model trained on one population can underperform for patients who were underrepresented in the training data. Validate performance by subgroup before deployment and monitor it afterward. Interoperability is the third: twins need clean, standardized data, but data standards within healthcare are still uneven, and most health systems are reconciling codes across EHR instances. That is where many digital twin in healthcare projects stall.
The last risk is organizational, and it is the same one that sinks most digital transformation work. Academic papers on challenges and future directions in this field list the same gaps: validation methods, data standards and governance. Vendor decks promise digital twins will revolutionize healthcare; the more useful question is which healthcare delivery decision the twin improves and who is accountable when it's wrong.
Build or buy: platforms, integrators and the questions to ask
Most health systems should buy the platform and build the model. General-purpose digital twin technologies from cloud and industrial vendors handle data ingestion, simulation engines and visualization. The value you add in digital twin development is the clinical or operational logic and the data integration, which no vendor can do without your teams. Integrating digital twin technology with existing EHR and imaging systems is usually most of the project, and if you can't integrate digital twin outputs into the clinician's existing workflow, nobody will use them.
Ask every vendor the same questions, whether they sell a platform or packaged healthcare solutions. Where is the model hosted, and who can access patient data in it? Will you sign a BAA and show a current HITRUST or SOC 2 report scoped to this service? How is the twin validated, against what outcomes, and how often? Can we export our models and data if we leave? What happens to our data in your training sets?
Integrators matter as much as platforms, because digital twin technologies only pay off when someone connects them to how clinicians actually work. You need people who understand clinical workflows, HL7 and FHIR interfaces, and security architecture, and those rarely sit in one team. Our digital twin services team works alongside clinical informatics to scope that integration, and our cybersecurity consulting group reviews the data paths before go-live.
How to scope a first digital twin pilot
Health systems that use digital twins well start small. A first digital twin in healthcare pilot should cover one decision, one unit and one data set. A good first pilot predicts something operational, such as discharge timing on a single medical unit, where the data already exists, outcomes are measurable within weeks and a wrong prediction won't disrupt healthcare services. When a health system uses digital twins this way, implementing digital twin technology one decision at a time, it can prove the integration and security model before any patient-level use.
Define success before you start: a target accuracy, a measurable operational gain, and a security review completed before production data flows. Run the pilot for 90 days, compare the twin's predictions against what actually happened, and decide whether to expand, adjust or stop. The question is whether the twin delivered enhanced healthcare operations or just another dashboard. The same pattern we use for digital twin predictive maintenance in manufacturing applies here: narrow scope, real data, measured results.
Bring compliance in at the start, not the end. Have the privacy officer review data flows, update the risk analysis, and confirm BAAs before the first feed is turned on. If you need outside support for that review, our guide on how to choose a HIPAA consultant covers what to look for. For the wider landscape, see our guide to digital twin technology across industries.
Frequently asked questions
What is a digital twin in healthcare?
A live, data-fed virtual model of a patient, an organ or a hospital process that updates as new data arrives, so clinicians and operators can test decisions on the model before acting on the real thing.
What are the main use cases of digital twins in healthcare today?
Hospital operations twins that forecast beds, discharges and surges are the most mature. Organ-level models for procedure planning come next. Patient-level twins for personalized treatment are still mostly research.
Do digital twins fall under HIPAA?
Yes, when they create, receive, store or transmit ePHI. The Security Rule's safeguards apply: a risk analysis for each data feed, role-based access, audit logging, encryption and a business associate agreement with every vendor that touches the data.
Can digital twins reduce the size of clinical trials?
In some cases. EMA's 2022 qualification opinion for PROCOVA says prognostic models can increase statistical power or reduce the sample size needed for Phase 2 and 3 trials with continuous outcomes, though gains should be estimated conservatively.
How should a health system start a digital twin project?
Pick one operational decision on one unit with data you already have, define success criteria and a security review up front, run a 90-day pilot, and compare predictions with actual outcomes before expanding.
Planning a digital twin pilot for your health system?
VisioneerIT helps healthcare organizations scope, secure and govern digital twin healthcare programs, from the first data-flow map to the HIPAA risk analysis and model governance. If your twin uses machine learning, our AI governance and compliance practice can set up the validation and monitoring an auditor will ask for. Talk to our team about a 90-day pilot plan.
Key Things to Remember
- A digital twin stays connected to its physical counterpart; a one-off simulation or a dashboard isn't a twin.
- Hospital operations twins are the most mature use today; patient-level twins are still mostly research.
- EMA's 2022 PROCOVA opinion supports smaller trial samples with the same statistical power, not trials without control groups.
- Every data feed into a twin is a PHI path that needs a risk analysis, access controls, logging and a BAA.
- A detailed patient twin can be re-identifiable even after Safe Harbor de-identification.
- Ask for the vendor's HITRUST or SOC 2 report and check that its scope covers the service hosting your model.
- Start with one operational decision, a 90-day pilot and success criteria defined up front.
